Related Experiment Video
Updated: Jun 21, 2025

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells
Tatsuya Terasaki1, Yuichiro Semba1,2, Kensuke Sasaki1,3
1Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
Abstract:
Selinexor, a first-in-class exportin1 (XPO1) inhibitor, is an attractive anti-tumor agent because of its unique mechanisms of action; however, its dose-dependent toxicity and lack of biomarkers preclude its wide use in clinical applications. To identify key molecules/pathways regulating selinexor sensitivity, we performed genome-wide CRISPR/Cas9 dropout screens using two B-ALL lines. We identified, for the first time, that paralogous DDX19A and DDX19B RNA helicases modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export. While single depletion of either DDX19A or DDX19B barely altered MCL1 protein levels, depletion of both significantly attenuated MCL1 mRNA nuclear export, reducing MCL1 protein levels. Importantly, combining selinexor treatment with depletion of either DDX19A or DDX19B markedly induced intrinsic apoptosis of leukemia cells, an effect rescued by MCL1 overexpression. Analysis of Depmap datasets indicated that a subset of T-ALL lines expresses minimal DDX19B mRNA levels. Moreover, we found that either selinexor treatment or DDX19A depletion effectively induced apoptosis of T-ALL lines expressing low DDX19B levels. We conclude that XPO1 and DDX19A/B coordinately regulate cellular MCL1 levels and propose that DDX19A/B could serve as biomarkers for selinexor treatment. Moreover, pharmacological targeting of DDX19 paralogs may represent a potential strategy to induce intrinsic apoptosis in leukemia cells.
Insights
Selinexor sensitivity in leukemia is regulated by DDX19A/B RNA helicases controlling MCL1 export. Targeting these helicases alongside selinexor induces apoptosis, suggesting DDX19A/B as potential biomarkers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Selinexor, an exportin1 (XPO1) inhibitor, shows anti-tumor potential but faces clinical limitations due to toxicity and lack of predictive biomarkers.
- Identifying molecular regulators of selinexor sensitivity is crucial for optimizing its therapeutic application in leukemia.
Purpose of the Study:
- To uncover key molecules and pathways influencing selinexor sensitivity in B-acute lymphoblastic leukemia (B-ALL).
- To investigate the role of DDX19A and DDX19B RNA helicases in selinexor response and MCL1 regulation.
Main Methods:
- Genome-wide CRISPR/Cas9 dropout screens were employed in B-ALL cell lines.
- MCL1 mRNA nuclear export and protein levels were assessed following DDX19A/B depletion.
- Synergistic effects of selinexor and DDX19A/B depletion on leukemia cell apoptosis were evaluated.
- Depmap datasets were analyzed to assess DDX19B expression in T-ALL lines.
Main Results:
- DDX19A and DDX19B were identified as novel modulators of selinexor sensitivity by regulating MCL1 mRNA nuclear export.
- Dual depletion of DDX19A/B significantly reduced MCL1 protein levels and enhanced selinexor-induced apoptosis.
- MCL1 overexpression rescued the apoptotic effect, confirming its role in selinexor sensitivity.
- T-ALL lines with low DDX19B expression showed sensitivity to selinexor or DDX19A depletion.
Conclusions:
- Exportin1 (XPO1) and DDX19A/B RNA helicases coordinately regulate cellular MCL1 levels.
- DDX19A/B paralogs show promise as biomarkers for predicting selinexor treatment response.
- Targeting DDX19 paralogs presents a potential therapeutic strategy to induce apoptosis in leukemia.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
09:16Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
Related Concept Videos
Nuclear Export of mRNA
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Nuclear Export
NES are of three types- the canonical 10-residue long leucine-rich signal and other...
Chromatin Structure Regulates pre-mRNA Processing
The chromatin structure, especially...